Citadel Advisors’s Athenahealth, Inc. ATHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-145,900
| Closed | -$19.2M | – | 10309 |
|
|
2018
Q4 | $19.2M | Sell |
145,900
-74,000
| -34% | -$9.48M | 0.01% | 1262 |
|
|
2018
Q3 | $29.4M | Buy |
219,900
+84,000
| +62% | +$12.6M | 0.01% | 1098 |
|
|
2018
Q2 | $21.6M | Buy |
135,900
+100,600
| +285% | +$14.9M | 0.01% | 1243 |
|
|
2018
Q1 | $5.05M | Sell |
35,300
-45,800
| -56% | -$6.26M | ﹤0.01% | 2441 |
|
|
2017
Q4 | $10.8M | Buy |
81,100
+19,800
| +32% | +$2.53M | 0.01% | 1662 |
|
|
2017
Q3 | $7.62M | Buy |
61,300
+22,900
| +60% | +$3.15M | 0.01% | 1870 |
|
|
2017
Q2 | $5.4M | Buy |
38,400
+5,500
| +17% | +$687K | ﹤0.01% | 2049 |
|
|
2017
Q1 | $3.71M | Sell |
32,900
-25,400
| -44% | -$2.96M | ﹤0.01% | 2357 |
|
|
2016
Q4 | $6.13M | Buy |
58,300
+11,400
| +24% | +$1.23M | 0.01% | 1781 |
|
|
2016
Q3 | $5.92M | Sell |
46,900
-200
| -0.4% | -$25.4K | 0.01% | 1817 |
|
|
2016
Q2 | $6.5M | Sell |
47,100
-12,100
| -20% | -$1.6M | 0.01% | 1599 |
|
|
2016
Q1 | $8.22M | Sell |
59,200
-36,700
| -38% | -$5.03M | 0.01% | 1349 |
|
|
2015
Q4 | $15.4M | Sell |
95,900
-19,800
| -17% | -$3.06M | 0.02% | 994 |
|
|
2015
Q3 | $15.4M | Buy |
115,700
+19,900
| +21% | +$2.6M | 0.01% | 1068 |
|
|
2015
Q2 | $11M | Sell |
95,800
-44,900
| -32% | -$5.37M | 0.01% | 1401 |
|
|
2015
Q1 | $16.8M | Buy |
140,700
+3,800
| +3% | +$506K | 0.02% | 1081 |
|
|
2014
Q4 | $19.9M | Sell |
136,900
-1,500
| -1% | -$188K | 0.02% | 945 |
|
|
2014
Q3 | $18.2M | Buy |
138,400
+24,000
| +21% | +$3.16M | 0.02% | 961 |
|
|
2014
Q2 | $14.3M | Buy |
114,400
+22,800
| +25% | +$2.95M | 0.02% | 1019 |
|
|
2014
Q1 | $14.7M | Sell |
91,600
-20,000
| -18% | -$3.29M | 0.02% | 1034 |
|
|
2013
Q4 | $15M | Buy |
111,600
+31,800
| +40% | +$4.09M | 0.02% | 960 |
|
|
2013
Q3 | $8.66M | Buy |
79,800
+19,000
| +31% | +$2.05M | 0.01% | 1192 |
|
|
2013
Q2 | $5.15M | Buy |
+60,800
| New | +$5.44M | 0.01% | 1547 |
|
Citadel Advisors's ATHN Position: Q1 2019 in Review
Citadel Advisors sold out of Athenahealth, Inc. (ATHN) in Q1 2019, closing a stake of 794,608 shares — an estimated $105M sold.
Citadel Advisors first reported a position in ATHN in Q2 2013 and held it in 22 quarters. The position peaked at $105M in Q4 2018. 0 funds tracked by Wall St. Rank hold ATHN as of Q1 2019.
- Citadel Advisors reported no remaining Athenahealth, Inc. position as of Q1 2019 after selling out during the quarter.
- Citadel Advisors sold 794,608 Athenahealth, Inc. shares in Q1 2019, an estimated $105M.
- Citadel Advisors first reported a position in Athenahealth, Inc. in Q2 2013 and held it in 22 quarters.
- Citadel Advisors's Athenahealth, Inc. position peaked at $105M in Q4 2018.
- 0 funds tracked by Wall St. Rank held Athenahealth, Inc. as of Q1 2019.
Based on Citadel Advisors's 13F filing for Q1 2019, filed 15 May 2019.